Wockhardt is planning to roll out two vaccines within a year from its UK-based facility as part of a tie-up with Serum Institute of India. Last year, a Wockhardt unit tied up with a subsidiary of Serum Institute of India to set up a vaccine manufacturing facility in Wrexham, North Wales (UK).
Serum has identified two vaccines and the company plans to manufacture these products within the next 12 months after exhibit batches and regulatory approval is received.
Wockhardt is a research based global pharmaceutical and Biotech Company headquartered in Mumbai, India.
